Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L04 IMMUNOSUPPRESSANTS
      L04A IMMUNOSUPPRESSANTS
        L04AC Interleukin inhibitors [DG:DG02019]
          L04AC12 Brodalumab
            D10061  Brodalumab (USAN) <JP/US>

USP drug classification [BR:br08302]
  Immunological Agents
    Immunological Agents, Other
      Interleukin Blockers
        Brodalumab
          D10061  Brodalumab (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  3  Agents affecting metabolism
    39  Other agents affecting metabolism
      399  Miscellaneous
        3999  Others
          D10061  Brodalumab (USAN); Brodalumab (genetical recombination) (JAN)

Drug groups [BR:br08330]
  Immunological agent
    DG02019  Interleukin inhibitor
      D10061  Brodalumab

Drug classes [BR:br08332]
  Immunological agent
    DG02019  Interleukin inhibitor
      D10061  Brodalumab

Target-based classification of drugs [BR:br08310]
  Cytokines and receptors
    Cytokine receptors
      Interleukin receptors
        IL17RA (CD217) [HSA:23765] [KO:K05164]
          D10061  Brodalumab (USAN) <JP/US>

New drug approvals in the USA [br08319.html]
  D10061

New drug approvals in Europe [br08329.html]
  D10061

New drug approvals in Japan [br08318.html]
  D10061

New drug approvals in the USA, Europe and Japan [br08328.html]
  D10061